Drug Shortage Report for TARO-TERCONAZOLE

Last updated on 2020-03-21 History
Report ID 107025
Drug Identification Number 02247651
Brand name TARO-TERCONAZOLE CREAM
Common or Proper name TERCONAZOLE CREAM
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) TERCONAZOLE
Strength(s) 0.4%
Dosage form(s) CREAM
Route of administration VAGINAL
Packaging size 45 g
ATC code G01AG
ATC description ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-02-21
Estimated end date 2020-03-20
Actual end date 2020-03-20
Shortage status Resolved
Updated date 2020-03-21
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2020-03-21 English Compare
v8 2020-03-20 French Compare
v7 2020-03-20 English Compare
v6 2020-03-16 French Compare
v5 2020-03-16 English Compare
v4 2020-03-07 French Compare
v3 2020-03-07 English Compare
v2 2020-02-24 French Compare
v1 2020-02-24 English Compare

Showing 1 to 9 of 9